Your browser doesn't support javascript.
loading
Persistence of symptoms in dengue patients: a clinical cohort study.
Tiga-Loza, Diana Carolina; Martínez-Vega, Ruth A; Undurraga, Eduardo A; Tschampl, Cynthia A; Shepard, Donald S; Ramos-Castañeda, José.
Afiliação
  • Tiga-Loza DC; Programa de enfermería, Universidad Manuela Beltrán, Bucaramanga, Santander, Colombia.
  • Martínez-Vega RA; Centro de investigaciones sobre enfermedades infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
  • Undurraga EA; Escuela de Microbiología, Universidad Industrial de Santander, Bucaramanga, Santander, Colombia.
  • Tschampl CA; Escuela de Gobierno, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Shepard DS; Millennium Nucleus for the Study of the Life Course and Vulnerability (MLIV), Chile.
  • Ramos-Castañeda J; Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, Massachusetts, USA.
Trans R Soc Trop Med Hyg ; 114(5): 355-364, 2020 05 07.
Article em En | MEDLINE | ID: mdl-32125417
ABSTRACT

BACKGROUND:

Dengue is commonly considered an acute illness and follows three phases febrile, critical in some cases and recovery. However, a number of studies have described a continuation of dengue symptoms for weeks or months, extending the recovery phase. Here we evaluate this persistence of dengue symptoms during convalescence.

METHODS:

Our clinical cohort study included patients who sought medical services 48 to 144 h from the onset of fever at seven hospitals or ambulatory centers in Morelos, Mexico. Seventy-nine laboratory-confirmed dengue patients were followed up regularly using clinic and/or home visits and telephone calls for as long as symptoms persisted or up to 6 mo.

RESULTS:

In total, 55.7% of patients had dengue-related symptoms 1 mo after the onset of fever; pain and dermatological manifestations were the most common persistent symptoms. Prognostic factors for symptom persistence were ≥4 d of fever (RR 1.72; 95% CI 1.35 to 2.19), platelet count ≤100 000/mm3 (RR 1.20; 95% CI 1.20 to 2.20), petechiae/bruises (RR 1.97; 95% CI 1.56 to 2.48) and abdominal pain/hepatomegaly (RR 1.79; 95% CI 1.41 to 2.28).

CONCLUSIONS:

Persistence of dengue symptoms were common in laboratory-confirmed dengue patients. Manifestations related to tissue damage were associated with persistence after 30 d; host characteristics, such as age and health status before infection, were associated with prolonged persistence (>60 d). The burden of dengue may be higher than previously estimated.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Mexico Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Mexico Idioma: En Ano de publicação: 2020 Tipo de documento: Article